Study of ORL-1M (D-mannose) in Patients With CDG-Ib

Last updated: January 22, 2019
Sponsor: Orpha Labs
Overall Status: Active - Recruiting

Phase

1/2

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT03404869
PMID-1
  • Ages < 18
  • All Genders

Study Summary

Study of ORL-1M in Patients With CDG-Ib

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Diagnosis of CGD-1b.

  • Less than 18 years old.

Exclusion

Exclusion Criteria:

  • Diagnosis of any other disease that is not a manifestation of CGD-1b.

Study Design

Total Participants: 5
Study Start date:
March 31, 2015
Estimated Completion Date:
June 01, 2019

Connect with a study center

  • Orpha Labs

    Ankara, 06100
    Turkey

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.